Search

everythinglearnresearchcommunity

for

Search:↓

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Dermatologists are more comfortable and proactive in treating male pattern hair loss than primary care physicians.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Genomic approach finds new possible treatments for hair loss.

New technologies help us better understand how skin microbes affect skin diseases.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Weight loss can cause temporary hair loss, especially in women and older adults.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Nutrition affects skin health differently based on age and condition.

A newly found RNA in Cashmere goats may play a role in hair growth and development.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

Male C57BL/6 mice show age-related fluctuations in certain hormones and their ratios in both blood and hair.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Australian court ruled that Bickfords did not infringe on Monster Energy's trade mark because Monster was not sold or known in Australia at the time.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Innovative biomaterials show promise in healing chronic diabetic foot ulcers.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

New evaluation tools are needed for better surgical training in dermatology residency programs.